Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Terry Dagnon Insider Profile
11 Followers
Terry Dagnon, COO at Outlook Therapeutics, holds 653.06K shares in Outlook Therapeutics (Ticker: OTLK). Most recently, Terry Dagnon Sold $520,000 shares of Outlook Therapeutics on Apr 21, 2023 for an estimated value of 587.60K.
Profitable Transactions
4 out of 6 Profitable Transactions
Average Return
+19.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
COO
Roles that Terry Dagnon holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Apr 21, 2023 - Apr 21, 2024
Return:+65.00%
The most profitable trade made by Terry Dagnon
Terry Dagnon's Trading History
List of latest transactions for each holding click on a transaction to see Terry Dagnon's performance on stock
You May Also Like
Terry Dagnon insider profile FAQ
What is the percentage of profitable transactions made by Terry Dagnon?
The percentage of profitable transactions made by Terry Dagnon is 67%.
What is the average return per transaction made by Terry Dagnon?
The average return per transaction made by Terry Dagnon is 19.70%.
What stocks does Terry Dagnon hold?
Terry Dagnon holds: OTLK stocks.
What was Terry Dagnon’s latest transaction?
Terry Dagnon latest transaction was an Informative Sell of $587.60K.
What was Terry Dagnon's most profitable transaction?
Terry Dagnon’s most profitable transaction was an Informative Sell of OTLK stock on April 21, 2023. The return on the trade was 65.00%.
What is Terry Dagnon's role in Outlook Therapeutics?
Terry Dagnon's role in Outlook Therapeutics is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.